MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.

J Biol Chem

Department of Molecular Oncology, University of South Florida, Tampa, Florida; Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, Florida. Electronic address:

Published: October 2012


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Previous studies have shown aberrant expression of miR-214 in human malignancy. Elevated miR-214 is associated with chemoresistance and metastasis. In this study, we identified miR-214 regulation of ovarian cancer stem cell (OCSC) properties by targeting p53/Nanog axis. Enforcing expression of miR-214 increases, whereas knockdown of miR-214 decreases, OCSC population and self-renewal as well as the Nanog level preferentially in wild-type p53 cell lines. Furthermore, we found that p53 is directly repressed by miR-214 and that miR-214 regulates Nanog through p53. Expression of p53 abrogated miR-214-induced OCSC properties. These data suggest the critical role of miR-214 in OCSC via regulation of the p53-Nanog axis and miR-214 as a therapeutic target for ovarian cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471722PMC
http://dx.doi.org/10.1074/jbc.M112.374611DOI Listing

Publication Analysis

Top Keywords

ovarian cancer
12
mir-214
9
mir-214 regulates
8
targeting p53/nanog
8
expression mir-214
8
ocsc properties
8
microrna mir-214
4
regulates ovarian
4
cancer cell
4
cell stemness
4

Similar Publications

Objective: To identify and evaluate the methodological quality and psychometric properties of Patient-reported outcome measures (PROMs) for symptom assessment in patients with cancer undergoing immunotherapy.

Methods: A systematic search was performed in PubMed, Scopus, Cochrane Library, Web of Science, Embase, CINAHL, CNKI, WanFang, Vip, and SinoMed from their inception to February 10, 2025. Eligibility criteria required studies to focus on the development or validation of a PROM for symptom assessment in adult patients with cancer undergoing immunotherapy, and to report on at least one psychometric property.

View Article and Find Full Text PDF

Burden and trends of ovarian and uterine cancer due to high body mass index from 1990 to 2021: an age-period-cohort study based on the GBD 2021, and projections through 2036.

Front Oncol

August 2025

Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

Background: Ovarian cancer (OC) and uterine cancer (UC) are significant public health concerns among women of reproductive age. High body mass index (BMI) contributes to the increasing burden of these cancers globally, but comprehensive epidemiological assessments remain limited.

Methods: Data were obtained from the Global Burden of Disease (GBD) Study 2021 (1990-2021).

View Article and Find Full Text PDF

Introduction: Ovarian cancer has a high mortality rate due to late diagnosis, relapse and chemoresistance. miRNAs play a major role in tumorigenesis as well as chemoresistance. Hence, we undertook a study, to evaluate the differential expression of miRNAs in clinical specimens of ovarian cancer patients that may highlight the effect of chemotherapy and their role in predicting survival outcomes.

View Article and Find Full Text PDF

Extra-ovarian recurrence of mucinous cystadenomas (MCs) is a rare phenomenon. This case report presents the first documented instance of a benign MC recurring within the uterine myometrium of a 48-year-old woman. Two years following an oophorectomy for a large left ovarian MC, the patient presented with lower abdominal pain.

View Article and Find Full Text PDF

Objective In 2020, breast cancer was the most commonly diagnosed cancer among women in Japan. Its incidence begins to rise in the late twenties and reaches a first peak in the late forties. Therefore, fostering sustainable preventive health behaviors from a younger age is crucial.

View Article and Find Full Text PDF